Onconetix, Inc. - Common Stock (ONCO)

Onconetix Inc is a biotechnology company focused on advancing cancer diagnostics and therapeutics

The company leverages cutting-edge research and technology to develop innovative solutions aimed at improving patient outcomes in oncology. By harnessing the power of molecular biology and genomics, Onconetix aims to enhance the ability to detect and characterize tumors, enabling more effective treatment strategies tailored to individual patients. The company's commitment to precision medicine drives its ongoing efforts to contribute to the evolving landscape of cancer care through scientific discovery and collaboration.